EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
about
Potent and specific inhibition of glycosidases by small artificial binding proteins (affitins)The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis LungNew selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases2-O, 3-O-desulfated heparin inhibits neutrophil elastase-induced HMGB-1 secretion and airway inflammation.Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Extracellular proteases as targets for drug developmentThe pig as a model for investigating the role of neutrophil serine proteases in human inflammatory lung diseases.Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies.Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).Inhibitors of cathepsin G: a patent review (2005 to present).Shark variable new antigen receptor biologics - a novel technology platform for therapeutic drug development.Antiproteases as therapeutics to target inflammation in cystic fibrosis.A secretory leukocyte protease inhibitor variant with improved activity against lung infection.Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils.Protease inhibitors in respiratory disease: focus on asthma and chronic obstructive pulmonary disease.Biochemie 2009
P2860
Q21090623-35351027-7A15-40F9-97A8-7859997348C7Q26799771-AD2B4B86-6265-4A5E-AFD5-102947AE58EAQ27314812-66A7871F-3272-4EFE-B0BA-8485E2B75120Q33553441-025CDC0D-33F1-4425-A959-76104354524DQ33799602-23DF26E4-001B-440A-8B75-4886BDC368BBQ34149948-17DF2917-8704-4B28-B89F-2BF461AD058CQ35116202-B7AA74E4-FC9F-4F34-9840-C40CEC588778Q36382772-D28D0810-EA3D-46CC-84A7-47AE0617A51BQ37332258-CFCDF48F-1E53-4D8F-A140-B4C583675503Q38079492-D41B8A5F-20C6-45E6-8C54-E8880AD25E8AQ38147399-759129D2-1ECA-4B8F-A963-72B4AECC2B3DQ38236706-98E2CA76-4E37-4D90-A68C-C895E17E8C43Q40363808-A7E360A2-A19C-4335-A1FF-DC04FAC4ECE6Q40996531-B4216192-B502-40C5-AD82-D6685B155D15Q42550003-CDDF9080-913B-4CB4-89EC-BB0E87393B95Q43061558-A7213867-98CA-4137-A6CD-789D11FC5EC9Q57260233-BA285BE6-7DE5-4806-B05C-11C2B3D96EC7
P2860
EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
EPI-hNE4, a proteolysis-resist ...... for treating cystic fibrosis.
@ast
EPI-hNE4, a proteolysis-resist ...... for treating cystic fibrosis.
@en
EPI-hNE4, a proteolysis-resist ...... for treating cystic fibrosis.
@nl
type
label
EPI-hNE4, a proteolysis-resist ...... for treating cystic fibrosis.
@ast
EPI-hNE4, a proteolysis-resist ...... for treating cystic fibrosis.
@en
EPI-hNE4, a proteolysis-resist ...... for treating cystic fibrosis.
@nl
prefLabel
EPI-hNE4, a proteolysis-resist ...... for treating cystic fibrosis.
@ast
EPI-hNE4, a proteolysis-resist ...... for treating cystic fibrosis.
@en
EPI-hNE4, a proteolysis-resist ...... for treating cystic fibrosis.
@nl
P2093
P356
P1476
EPI-hNE4, a proteolysis-resist ...... g for treating cystic fibrosis
@en
P2093
Alexandre Gauthier
Francis Gauthier
François Saudubray
Michèle Ferrer-Di Martino
Pascal Delépine
Patrice Diot
Sylvie Attucci
P304
P356
10.1124/JPET.106.103440
P407
P577
2006-04-20T00:00:00Z